GLSI
Greenwich Lifesciences Inc
15.10$
-1.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.9% | 99.9% | 99.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.9% | 99.9% | 99.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.9% | – | 99.9% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | |
| 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | |
| 3.2% | 4.2% | 7.1% | 18.7% | 14.5% | 38.1% | 52.3% | 53.9% | 42.6% | 94.3% | 49.8% | 64.9% | |
| 3.2% | 4.2% | 7.1% | 18.7% | 14.5% | 38.1% | 52.3% | 53.9% | 42.6% | 94.3% | 49.8% | 64.9% | |
| 0.1% | 3.7% | 2.3% | 15.4% | 13.3% | 28.8% | 30.1% | 34.4% | 29.1% | 78.9% | 42.9% | 54.2% | |
| 96.8% | 95.8% | 92.9% | 81.3% | 85.5% | 61.9% | 47.7% | 46.1% | 57.4% | 5.7% | 50.2% | 35.1% | |
| -520.4% | -720.0% | -958.9% | -767.0% | -997.6% | -1,616.0% | -2,523.3% | -2,349.9% | -2,038.1% | -1,410.4% | -883.3% | -1,089.9% | |
| 140.4% | 183.7% | 233.4% | 178.6% | 225.6% | 321.3% | 478.8% | 427.9% | 358.3% | 231.4% | 138.6% | 164.7% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.